• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Danaher Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    7/24/25 4:50:27 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials
    Get the next $DHR alert in real time by email
    dhr-20250721
    False000031361600003136162025-07-212025-07-210000313616us-gaap:CommonStockMember2025-07-212025-07-210000313616dhr:A0.2SeniorNotesDue2026Member2025-07-212025-07-210000313616dhr:A2.1SeniorNotesDue2026Member2025-07-212025-07-210000313616dhr:A1.2SeniorNotesDue2027Member2025-07-212025-07-210000313616dhr:A0.45SeniorNotesDue2028Member2025-07-212025-07-210000313616dhr:A2.5SeniorNotesDue2030Member2025-07-212025-07-210000313616dhr:A0.75SeniorNotesDue2031Member2025-07-212025-07-210000313616dhr:A1.35SeniorNotesDue2039Member2025-07-212025-07-210000313616dhr:A1.8SeniorNotesDue2049Member2025-07-212025-07-21

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    __________________
    FORM 8-K
    __________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of report (Date of earliest event reported): July 21, 2025
    __________________
    dhrlogo.jpg
    DANAHER CORPORATION
    (Exact Name of Registrant as Specified in Its Charter)
    __________________
    Delaware001-0808959-1995548
    (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
    2200 Pennsylvania Avenue, N.W., 20037-1701
    Suite 800W
    Washington,DC
    (Address of Principal Executive Offices) (Zip Code)
    202-828-0850
    (Registrant’s Telephone Number, Including Area Code)
    Not applicable
    (Former Name or Former Address, if Changed Since Last Report)
    __________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, $0.01 par valueDHRNew York Stock Exchange
    0.200% Senior Notes due 2026DHR/26New York Stock Exchange
    2.100% Senior Notes due 2026DHR 26New York Stock Exchange
    1.200% Senior Notes due 2027DHR/27New York Stock Exchange
    0.450% Senior Notes due 2028DHR/28New York Stock Exchange
    2.500% Senior Notes due 2030DHR 30New York Stock Exchange
    0.750% Senior Notes due 2031DHR/31New York Stock Exchange
    1.350% Senior Notes due 2039DHR/39New York Stock Exchange
    1.800% Senior Notes due 2049DHR/49New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 



    ITEM 5.02DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
    On July 21, 2025, Matthew M. McGrew, Executive Vice President and Chief Financial Officer of Danaher Corporation (the “Company” or “Danaher”), notified the Company that he plans to relinquish his role as Chief Financial Officer as of February 28, 2026, after which he will continue as an Executive Vice President of the Company. Effective February 28, 2026, Matthew E. Gugino will succeed Mr. McGrew as Executive Vice President-Chief Financial Officer. Mr. Gugino, 43, currently serves as Danaher’s Vice President-Corporate FP&A and Group CFO with responsibility for the Life Sciences Innovations businesses. Since joining Danaher in 2013, Mr. Gugino has served in a series of progressively more responsible positions in the Company’s finance and investor relations organizations, including as Vice President-Investor Relations from 2014 to March 2022. He assumed the FP&A portion of his current role in July 2019 and the Group CFO portion of his current role in April 2021.
    In connection with Mr. Gugino’s promotion, on July 21, 2025, the Compensation Committee of Danaher’s Board of Directors approved the following changes to Mr. Gugino’s compensation, as set forth in a letter agreement subsequently entered into between the Company and Mr. Gugino as of July 21, 2025 (“Letter Agreement”):
    •effective as of July 21, 2025, Mr. Gugino’s annual base salary rate increases to $700,000 and his target bonus percentage under the Company’s annual cash incentive compensation program for the remainder of the year increases to 90%;
    •Mr. Gugino will receive an equity award in November 2025 (representing a pro-rated portion of a higher annual award value) with a target dollar value of $1,750,000, to be split equally between stock options and time-vesting restricted stock units;
    •effective as of February 28, 2026, Mr. Gugino’s annual base salary rate will increase to $825,000 and he will participate in the Company’s annual executive cash incentive compensation program with a target bonus percentage of 115%;
    •the target dollar value of equity compensation to be awarded to Mr. Gugino in 2026 (to be awarded in accordance with the Company’s standard procedures and timing for annual executive officer equity awards) will be $4,200,000, to be split equally between stock options and performance stock units; and
    •pursuant to the Company’s Senior Leaders Severance Pay Plan, the total amount of severance pay for which Mr. Gugino would be eligible upon a qualifying termination would be equal to his annual base salary at the time of termination.
    As of February 28, 2026, Mr. Gugino will also be entitled to personal use of the Danaher aircraft up to $50,000 annually, reimbursement for financial/tax planning and tax preparation services in an amount not to exceed $15,000 annually, parking, an annual physical and tickets to sports and entertainment events.
    In connection with Mr. Gugino’s promotion and the changes in his compensation set forth above, the Company and Mr. Gugino also entered into an Agreement Regarding Competition and Protection of Proprietary Interests as of July 21, 2025 (the “Protection of Proprietary Interests Agreement”). Under this agreement, during and for specified periods after Mr. Gugino’s employment with the Company, subject to certain customary exceptions, he is prohibited from disclosing or improperly using any of the Company’s confidential information; making any disparaging comments about the Company; competing with the Company; selling to or soliciting purchases from the Company’s customers and prospective customers with respect to products and services about which he has particular knowledge or expertise; hiring or soliciting any of the Company’s current or recent employees, or otherwise assisting or encouraging any of the Company’s employees to leave; interfering with the Company’s vendor relationships; or developing competing products or services. Mr. Gugino also agrees that with limited exceptions all intellectual property that he develops in connection with his employment with the Company belongs to the Company, and assigns the Company all rights he may have in any such intellectual property.
    The foregoing descriptions of the Letter Agreement and Protection of Proprietary Interests Agreement are qualified in their entirety by reference to the full text of such agreements, which are attached as Exhibit 10.1 and Exhibit 10.2, respectively, to this report and incorporated in this report by reference.
    There are no transactions in which Mr. Gugino has an interest requiring disclosure under Item 404(a) of Regulation S-K.
    In addition, in connection with the change of Mr. McGrew’s role, on July 21, 2025 Danaher’s Compensation Committee approved the following changes to Mr. McGrew’s compensation:
    •effective as of February 28, 2026, Mr. McGrew’s annual base salary rate will be $700,000 and his target bonus percentage under the Company’s annual cash incentive compensation program will be 125%; and



    •the target dollar value of equity compensation to be awarded to Mr. McGrew in 2026 (to be awarded in accordance with the Company’s standard procedures and timing for annual executive officer equity awards) will be $2,500,000, to be split equally between stock options and time-vested restricted stock units.
    The Company issued a press release on July 22, 2025 announcing the anticipated CFO transition. A copy of the press release is attached as Exhibit 99.1 to this report and incorporated by reference herein.

    ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
    (c)Exhibits:
    Exhibit No.  Description
    10.1 
    Letter Agreement by and between Danaher Corporation and Matthew Gugino dated July 21, 2025*
    10.2 
    Agreement Regarding Competition and Protection of Proprietary Interests by and between Danaher Corporation and Matthew Gugino dated July 21, 2025*
    99.1 
    Press release - "Danaher Announces Transition Plan for Chief Financial Officer"
    104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
    *Indicates management contract or compensatory plan, contract or arrangement.



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    DANAHER CORPORATION
    Date:July 22, 2025By:/s/ James F. O’Reilly
    James F. O’Reilly
    Senior Vice President, Deputy General Counsel and Secretary; Chief Sustainability Officer


    Get the next $DHR alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $DHR

    DatePrice TargetRatingAnalyst
    7/11/2025$275.00Sector Perform → Sector Outperform
    Scotiabank
    4/10/2025$205.00Equal Weight → Overweight
    Barclays
    3/21/2025$260.00Neutral → Buy
    Goldman
    3/14/2025$260.00Hold → Buy
    Stifel
    2/3/2025Outperform → Mkt Perform
    Raymond James
    12/23/2024Sector Perform
    Scotiabank
    12/19/2024$275.00Buy
    Guggenheim
    12/13/2024$290.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $DHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Danaher upgraded by Scotiabank with a new price target

      Scotiabank upgraded Danaher from Sector Perform to Sector Outperform and set a new price target of $275.00

      7/11/25 7:56:02 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher upgraded by Barclays with a new price target

      Barclays upgraded Danaher from Equal Weight to Overweight and set a new price target of $205.00

      4/10/25 8:28:29 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher upgraded by Goldman with a new price target

      Goldman upgraded Danaher from Neutral to Buy and set a new price target of $260.00

      3/21/25 8:01:35 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    SEC Filings

    See more
    • Danaher Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - DANAHER CORP /DE/ (0000313616) (Filer)

      7/24/25 4:50:27 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-Q filed by Danaher Corporation

      10-Q - DANAHER CORP /DE/ (0000313616) (Filer)

      7/21/25 6:39:11 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - DANAHER CORP /DE/ (0000313616) (Filer)

      7/21/25 5:47:55 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Danaher Announces Transition Plan for Chief Financial Officer

      WASHINGTON, July 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financial Officer of the Company's Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher's Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, Mr. McGrew will continue thereafter as an Executive Vice President of the Company, as he begins a gradual transition to retirement, after more than 20 years with Danaher. "Matt McGrew's financial leadership over the past two decades

      7/22/25 6:02:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Reports Second Quarter 2025 Results

      WASHINGTON, July 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) (the "Company") today announced results for the quarter ended June 27, 2025. Key Second Quarter 2025 Results Net earnings were $555 million, or $0.77 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.80.Revenues increased 3.5% year-over-year to $5.9 billion and non-GAAP core revenue increased 1.5% year-over-year.Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.Rainer M. Blair, President and Chief Executive Officer, stated, "Our team's strong execution using the Danaher Business System, paired with another quarter of robust growth in our Bioproc

      7/22/25 6:00:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Appoints Martin Stumpe as Chief Technology and AI Officer

      WASHINGTON, June 27, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher's digital transformation and its ambition to lead the next era of innovation in life sciences and diagnostics. Under Dr. Stumpe's leadership, Danaher will seek to accelerate the integration of AI across its global businesses—unlocking new levels of scientific discovery, operational efficiency and clinical impact. "Danaher i

      6/27/25 7:35:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Zerhouni Elias A. exercised 3,928 shares at a strike of $59.34 and covered exercise/tax liability with 1,209 shares, increasing direct ownership by 7% to 40,805 units (SEC Form 4)

      4 - DANAHER CORP /DE/ (0000313616) (Issuer)

      7/16/25 5:01:31 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Director Schwieters John T exercised 3,928 shares at a strike of $59.34 and covered exercise/tax liability with 1,209 shares, increasing direct ownership by 16% to 19,815 units (SEC Form 4)

      4 - DANAHER CORP /DE/ (0000313616) (Issuer)

      7/16/25 5:01:02 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • VP, Chief Accounting Officer Bouda Christopher covered exercise/tax liability with 61 shares, decreasing direct ownership by 0.73% to 8,325 units (SEC Form 4)

      4 - DANAHER CORP /DE/ (0000313616) (Issuer)

      7/16/25 5:00:32 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Leadership Updates

    Live Leadership Updates

    See more
    • Danaher Appoints Martin Stumpe as Chief Technology and AI Officer

      WASHINGTON, June 27, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher's digital transformation and its ambition to lead the next era of innovation in life sciences and diagnostics. Under Dr. Stumpe's leadership, Danaher will seek to accelerate the integration of AI across its global businesses—unlocking new levels of scientific discovery, operational efficiency and clinical impact. "Danaher i

      6/27/25 7:35:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences

      WASHINGTON, June 27, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the Life Sciences Innovations Group since 2021. With this expanded role, he will become an executive officer of Danaher and will continue reporting to Rainer Blair, President and Chief Executive Officer. "Greg has played a pivotal role in advancing our Life Sciences Innovations Group over the past f

      6/27/25 7:30:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Announces Appointment of Charles Lamanna to Danaher Board

      WASHINGTON, Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Committee. Mr. Lamanna is currently Corporate Vice President, Business & Industry Copilot at Microsoft (NASDAQ:MSFT), where he drives product innovation in AI-powered business applications, low-code platforms, and autonomous agents. He oversees the design, product development, and engineering of some of Microsoft's most transformative technologies, including Power Platform, Dynamics 365, and Copilot Studio. Prior to that, Mr. Lamanna was the founder and CEO of MetricsHub, one of the first public cloud

      2/20/25 4:45:00 PM ET
      $DHR
      $MSFT
      Industrial Machinery/Components
      Industrials
      Computer Software: Prepackaged Software
      Technology

    $DHR
    Financials

    Live finance-specific insights

    See more
    • Danaher Reports Second Quarter 2025 Results

      WASHINGTON, July 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) (the "Company") today announced results for the quarter ended June 27, 2025. Key Second Quarter 2025 Results Net earnings were $555 million, or $0.77 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.80.Revenues increased 3.5% year-over-year to $5.9 billion and non-GAAP core revenue increased 1.5% year-over-year.Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.Rainer M. Blair, President and Chief Executive Officer, stated, "Our team's strong execution using the Danaher Business System, paired with another quarter of robust growth in our Bioproc

      7/22/25 6:00:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Schedules Second Quarter 2025 Earnings Conference Call

      WASHINGTON, June 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2025 on Tuesday, July 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You

      6/17/25 4:30:00 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Announces Quarterly Dividend

      WASHINGTON, May 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and h

      5/6/25 4:15:00 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

      SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

      2/9/23 11:16:32 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

      SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

      2/9/22 3:43:35 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13D/A filed by Danaher Corporation (Amendment)

      SC 13D/A - DANAHER CORP /DE/ (0000313616) (Subject)

      11/2/21 9:29:29 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials